Evidation Health will combine health outcomes data with new approaches to predictive analytics to identify and deploy the most effective and efficient patient management strategies and interventions.
“Our company has the core capabilities to make precision digital medicine a reality,” said Evidation Health CEO Deborah Kilpatrick. “We envision a digital health-enabled future where clinical interventions can be customized and concentrated in ways that maximize clinical and economic benefit for payers, providers and, most importantly, patients.”
Also to accelerate commercial progress, Evidation Health joined forces with The Activity Exchange, a digital health company with predictive analytics capabilities, and closed its Series A financing in January of 2015. The round was led by GE Ventures, with participation from Asset Management Ventures and Rock Health.
“With Evidation Health, we will be able to not only improve outcomes, but also ensure that the best products reach patients,” said Rowan Chapman, managing director of new business creation at GE Ventures.